Javascript must be enabled to continue!
8262 Non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) after gastric sleeve surgery
View through CrossRef
Abstract
Disclosure: R.E. Thomas: None. A. Charales: None. B. Bangash: None. S. Haider: None. S. Ouais: None.
Introduction: Non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) is a rare condition characterized by endogenous hyperinsulinemic hypoglycemia after meals. This article explores NIPHS, emphasizing its occurrence post-gastric sleeve surgery. We delve into clinical features, diagnosis, treatment, and challenges, using a case presentation to illustrate complexities.Clinical Features and Classification:NIPHS entails endogenous hyperinsulinemic hypoglycemia without islet cell neoplasms, featuring islet cell hypertrophy. Formerly "Nesidioblastosis," post-RYGB cases constitute a distinct diagnosis. Common features include postprandial hyperinsulinemic hypoglycemia, negative radiologic localization, and a positive calcium stimulation test.Patients present postprandial hypoglycemia 2-4 hours after meals, with symptoms like tachycardia, tremors, confusion, and occasional seizures. Lab findings include elevated insulin, C peptide, and pro-insulin, low beta-hydroxybutyrate, and negative sulfonylurea/meglitinide screen.Diagnostic Workup:Evaluate glucose, insulin, pro-insulin, C peptide, beta-hydroxybutyrate, and sulfonylurea/meglitinide. Ultrasound differentiates insulinoma from diffuse processes. If negative, conduct SACST for localization.Case Presentation:A 37-year-old female post-gastric sleeve surgery presented with severe hypoglycemia. Symptoms included confusion, nausea, and palpitations, occurring postprandially, relieved by food or juice. Glucagon was administered, and consultations sought. Diazoxide stabilized blood glucose.Treatment Modalities:Dietary modifications reduce free carbohydrate intake, spaced meals minimize hyperinsulinemic episodes. Medical management (octreotide, verapamil, diazoxide, acarbose) proves effective, especially post-gastric bypass. Sub-total pancreatectomy is considered in severe refractory cases.Multidisciplinary Approach:Management involves endocrinologists, surgeons, radiologists, and dietitians. Regular monitoring assesses efficacy, adjusts medications, and addresses complications. Challenges and Future Perspectives: NIPHS complexities include variable presentation and diagnostic challenges. Research should refine criteria, explore interventions, and understand pathophysiology. Conclusion: Non-insulinoma pancreatogenous hypoglycemia syndrome, especially post-gastric sleeve surgery, presents complexities. This exploration highlights clinical aspects, diagnostics, and management challenges, emphasizing the need for a multidisciplinary approach. Continued research aims to enhance diagnostic precision and improve outcomes for those affected by this intriguing syndrome.
Presentation: 6/3/2024
Title: 8262 Non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) after gastric sleeve surgery
Description:
Abstract
Disclosure: R.
E.
Thomas: None.
A.
Charales: None.
B.
Bangash: None.
S.
Haider: None.
S.
Ouais: None.
Introduction: Non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) is a rare condition characterized by endogenous hyperinsulinemic hypoglycemia after meals.
This article explores NIPHS, emphasizing its occurrence post-gastric sleeve surgery.
We delve into clinical features, diagnosis, treatment, and challenges, using a case presentation to illustrate complexities.
Clinical Features and Classification:NIPHS entails endogenous hyperinsulinemic hypoglycemia without islet cell neoplasms, featuring islet cell hypertrophy.
Formerly "Nesidioblastosis," post-RYGB cases constitute a distinct diagnosis.
Common features include postprandial hyperinsulinemic hypoglycemia, negative radiologic localization, and a positive calcium stimulation test.
Patients present postprandial hypoglycemia 2-4 hours after meals, with symptoms like tachycardia, tremors, confusion, and occasional seizures.
Lab findings include elevated insulin, C peptide, and pro-insulin, low beta-hydroxybutyrate, and negative sulfonylurea/meglitinide screen.
Diagnostic Workup:Evaluate glucose, insulin, pro-insulin, C peptide, beta-hydroxybutyrate, and sulfonylurea/meglitinide.
Ultrasound differentiates insulinoma from diffuse processes.
If negative, conduct SACST for localization.
Case Presentation:A 37-year-old female post-gastric sleeve surgery presented with severe hypoglycemia.
Symptoms included confusion, nausea, and palpitations, occurring postprandially, relieved by food or juice.
Glucagon was administered, and consultations sought.
Diazoxide stabilized blood glucose.
Treatment Modalities:Dietary modifications reduce free carbohydrate intake, spaced meals minimize hyperinsulinemic episodes.
Medical management (octreotide, verapamil, diazoxide, acarbose) proves effective, especially post-gastric bypass.
Sub-total pancreatectomy is considered in severe refractory cases.
Multidisciplinary Approach:Management involves endocrinologists, surgeons, radiologists, and dietitians.
Regular monitoring assesses efficacy, adjusts medications, and addresses complications.
Challenges and Future Perspectives: NIPHS complexities include variable presentation and diagnostic challenges.
Research should refine criteria, explore interventions, and understand pathophysiology.
Conclusion: Non-insulinoma pancreatogenous hypoglycemia syndrome, especially post-gastric sleeve surgery, presents complexities.
This exploration highlights clinical aspects, diagnostics, and management challenges, emphasizing the need for a multidisciplinary approach.
Continued research aims to enhance diagnostic precision and improve outcomes for those affected by this intriguing syndrome.
Presentation: 6/3/2024.
Related Results
The use of selective arterial calcium stimulation test in the diagnosis of the hyperinsulinemic hypoglycemia
The use of selective arterial calcium stimulation test in the diagnosis of the hyperinsulinemic hypoglycemia
We examined the patients with hyperinsulinemic hypoglycemia who were performed non-invasive imaging techniques with doubtful or failed results. We compared the performances of the ...
Continuous glucose monitoring in the ruling out recurrent insulinoma
Continuous glucose monitoring in the ruling out recurrent insulinoma
BACKGROUND: Currently, an annual study of venous glucose after night fasting is carried out to detect hypoglycemia for diagnosis the recurrence of insulinoma. However, hypoglycemia...
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
<i>Objectives: </i>The Hypoglycemia Fear Survey II (HFS-II) is a
well-validated measure of fear of hypoglycemia in people with type 1
diabetes. The aim of this study w...
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
<i>Objectives: </i>The Hypoglycemia Fear Survey II (HFS-II) is a
well-validated measure of fear of hypoglycemia in people with type 1
diabetes. The aim of this study w...
Hypoglycemia
Hypoglycemia
AbstractIatrogenic hypoglycemia often causes recurrent morbidity and precludes maintenance of lifelong euglycemia in people with diabetes mellitus. It causes an array of neurogenic...
Determination of effective riser sleeve thermophysical properties for simulation and analysis of riser sleeve performance
Determination of effective riser sleeve thermophysical properties for simulation and analysis of riser sleeve performance
<p>Riser sleeve thermophysical properties for simulation are developed using an inverse modeling technique. Casting experiments using riser sleeves are performed in order to ...
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
IntroductionRecurrent episodes of insulin-induced hypoglycemia in patients with diabetes mellitus can result in hypoglycemia-associated autonomic failure (HAAF), which is character...
Aquaporin 3 Expression Pattern in Gastric Diseases and its significance
Aquaporin 3 Expression Pattern in Gastric Diseases and its significance
Abstract
Background
Aquaporin 3(AQP3) has been implicated in gastric intestinal metaplasia and gastric cancer, and considered as a biomarker to improve treatment strategy....

